Galectins in Esophageal Cancer: Current Knowledge and Future Perspectives

SIMPLE SUMMARY: The overall 5-year survival rate of esophageal cancer patients is poor. Galectins are glycan-binding proteins known to contribute to tumor initiation and progression. To get insight in the expression and potential function of galectins in esophageal cancer we performed a literature r...

Descripción completa

Detalles Bibliográficos
Autores principales: Godefa, Tesfay M., Derks, Sarah, Thijssen, Victor L. J. L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9736038/
https://www.ncbi.nlm.nih.gov/pubmed/36497271
http://dx.doi.org/10.3390/cancers14235790

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9736038/
https://www.ncbi.nlm.nih.gov/pubmed/36497271
http://dx.doi.org/10.3390/cancers14235790

Ejemplares similares